Rho Webinars

  1. Understanding Common Causes Of Failure in Depression Studies 1/28/2019

    Dr. Jack Modell discusses why there is more to the story than placebo response in regards to the high failure rate of clinical studies in depression. Identify other factors that can contribute to failures and what steps can be taken to avoid those pitfalls.

  2. Understanding FDA's Priority Review Voucher System 1/28/2019

    How can one regulatory program simultaneously benefit both blockbuster drugs and rare or neglected diseases? How can your company leverage the opportunities afforded by this program? In this complimentary webinar, Rho’s panel of experts will walk you through the how’s and why’s of the FDA’s Priority Review Voucher program.

  3. Detecting, Handling, And Reporting Data Falsification, Misconduct, And/Or Suspected Fraud 1/28/2019

    Whether indications of fraud appear as missing documentation, altered numbers, signatures that don’t match, or unavailable medical records Clinical research associates (CRAs) must be aware of the many signs of possible fraud or fabricated data occurring at a clinical trial site. This webinar explains the signs to look for and the proper protocol to handle and report the misconduct during each monitoring visit.

  4. Small Size, Big Plans- Drug And Biologic Development Advice For Small Companies 10/17/2018

    This webinar will provide advice on how to set your small company up for long-term success through the use of strategic development plans, purposeful outsourcing, patent protection, partnership strategies, and provide specific examples of success stories and lessons learned.

  5. Bench To Clinic: Planning For A Successful Translation 10/17/2018

    This webinar will provide an overview of the clinical, nonclinical, CMC, and regulatory activities necessary for a successful IND submission.

  6. Using ePRO With Smart Devices 7/30/2015

    Interest in using electronic patient reported outcomes (ePRO) on smart devices is on the rise. In this webinar, Emily Cantrell and Becky Baggett will share lessons learned working on a large phase 3 pain study that utilizes ePRO on tablet devices.

  7. Keys to Success for Your Integrated Summary of Safety (ISS) and Integrated Summary of Efficacy (ISE) 4/23/2015

    Presenting the FDA with a coherent and clear integration of the data from your product development program is imperative and requires a sound strategy and a skillful approach.